SARS-CoV-2 infection
Disease1 paper
- Animals1
Trial sponsors
Company1 trialPhase 2410 people
Company1 trialPhase 24 people
1 trialPhase 475 people
Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
1 trialPhase 3356 people
Instituto de Investigación Marqués de Valdecilla
1 trialPhase 370 people
Collegium Medicum w Bydgoszczy
1 trialPhase 360 people
1 trialPhase 355 people
The University of Texas Health Science Center at San Antonio
1 trialPhase 228 people
Funding
National Institute on AgingUS$1.8m1 grant since 2023
Latest
13Annals of Internal MedicineHuman trial
Fluvoxamine may ease fatigue in adults with long COVID
Mean Fatigue Severity Scale scores were 0.43 points lower than placebo at day 60 and 0.58 points lower at day 90.Mean Fatigue Severity Scale scores were 0.43 points lower than placebo at day 60 and 0.58 points lower at day 90.
European Journal of Obstetrics, Gynecology, and Reproductive BiologyHumans
Temporal changes in serum anti-Müllerian hormone concentrations before, during, and after the COVID-19 pandemic: A retrospective study of 1799 women
Nature CommunicationsIn silico
Fast, flexible analysis of differences in cellular composition with crumblr
Molecular BiomedicineAnimals
A late-stage multi-dimensional intervention rescues lethal viral pneumonia in an aged hamster model
Science ImmunologyAnimals